Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1wbp | ADP | SRSF protein kinase 1 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1wbp | ADP | SRSF protein kinase 1 | 2.7.11.1 | 1.000 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.581 | |
| 3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.569 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.501 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.468 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 4c9p | CAM | Cytochrome P450 | / | 0.459 | |
| 4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
| 1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.457 | |
| 2w0b | CMW | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.456 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.453 | |
| 3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.451 | |
| 3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 4ihl | 1F5 | 14-3-3 protein zeta/delta | / | 0.448 | |
| 1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.447 | |
| 1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 2ovh | AS0 | Progesterone receptor | / | 0.445 | |
| 3e7i | B2 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.444 | |
| 4lwb | QJ8 | Nitric oxide synthase oxygenase | 1.14.13.165 | 0.444 | |
| 3e6o | A55 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.443 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 3blq | ATP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.442 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.440 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.440 | |
| 3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.440 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.440 |